Liver Hepatocellular Carcinoma (TCGA, Firehose Legacy)

Summary

Liver Hepatocellular Carcinoma (TCGA, Firehose Legacy) is a study catalogued by cBioPortal DataHub under the cancer-type code hcc. EvidenceHelix groups it with liver, bile duct and gallbladder studies and lists it in the TCGA Firehose Legacy collection.

Study description

TCGA Liver Hepatocellular Carcinoma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/LIHC/20160128/). Previously known as TCGA Provisional.

Text as published in the source's study metadata.

Citation & PubMed

The source lists no citation or PubMed id for this study.

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

lihc_tcga

Short name

Liver (TCGA)

Source cancer-type code

hcc

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data. TCGA data are available under the Broad Institute GDAC TCGA Analysis Pipeline License; TCGA-derived records are preliminary or legacy releases.

Citations

The source lists no citation or PubMed id for this study.

Related studies

• Hepatocellular Carcinoma (CLCA, Nature 2024)

  The Chinese Liver Cancer Atlas (CLCA) project. Deep whole-genome sequencing of 494 hepatocellular carcinomas and their matched normals. Data from CLC Atlas (http://lifeome.net:8080/clca/#/).

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

• Hepatocellular Carcinoma (MERiC/Basel, Nat Commun. 2022)

  Whole-exome sequencing of 122 Hepatocellular carcinomas and their matched normals. Dataset was generated in 2021 by MERiC and Charlotte Ng (hg19 original; Basel/Bern research pipeline).

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

• Hepatocellular Carcinoma (MSK, Clin Cancer Res 2018)

  MSK-IMPACT sequencing of 127 Hepatocellular Carcinoma tumor samples with matched normals.

  Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1

• Hepatocellular Carcinoma (MSK, Clin Cancer Res 2024)

  Targeted sequencing of 1,370 hepatobiliary cancer samples (with 1366 matched normals) via MSK-IMPACT. This data is available under the Creative Commons BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-…

  Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1

• Hepatocellular Carcinoma (MSK, JCO Precis Oncol 2023)

  Targeted sequencing of 51 hepatocellular carcinoma patients and their matched normal samples via MSK-IMPACT.

  Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1

• Hepatocellular Carcinomas (INSERM, Nat Genet 2015)

  Whole-exome sequencing of 243 liver tumors and matched normals.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

• Liver Hepatocellular Adenoma and Carcinomas (MSK, PLOS One 2018)

  Targeted sequencing of tumor/normal pairs of 9 LIAD and 10 HCC patients via MSK-IMPACT platform.

  Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1

• Liver Hepatocellular Carcinoma (AMC, Hepatology 2014)

  Whole exome sequencing of 231 hepatocellular carcinomas and matched normal tissue pairs.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.